Journal for ImmunoTherapy of Cancer (Nov 2021)

587 Inducing mismatch repair deficiency in combination with anti-CTLA4 therapy is highly effective against non-immunogenic neuroblastoma tumors

  • Saman Maleki,
  • Mikal El-Hajjar,
  • Mithunah Krishnamoorthy,
  • James Koropatnick,
  • Lara Gerhardt,
  • Rene Figueredo,
  • Xiufen Zheng

DOI
https://doi.org/10.1136/jitc-2021-SITC2021.587
Journal volume & issue
Vol. 9, no. Suppl 2

Abstract

Read online

No abstracts available.